Medical Devices
-
J&J boosts planned US manufacturing investment to $55B
Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.
By Jonathan Gardner • March 21, 2025 -
Retrieved from ICU Medical on March 21, 2025
Smiths Medical recalls port implants, warns on endotracheal tubes
The business, acquired by ICU Medical in 2022, has been dealing with a series of recalls and quality issues over the past several years.
By Susan Kelly • March 21, 2025 -
Explore the Trendline➔
Sitthiphong via Getty ImagesTrendlineMedical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
FDA posts early alert after Calyxo urinary stone device tied to death
The alert describes a problem that can lead to excessive pressure in the kidney during procedures to remove urinary stones.
By Nick Paul Taylor • March 21, 2025 -
Tariffs are paused for USMCA-compliant goods. How can companies qualify?
Businesses that previously found pursuing USMCA treatment cost-prohibitive are scrambling to determine if they meet the trade deal’s requirements.
By Philip Neuffer • March 20, 2025 -
Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
By Elise Reuter • March 20, 2025 -
Medtronic recalls embolization devices tied to 17 injuries, 4 deaths
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions for another model.
By Nick Paul Taylor • March 19, 2025 -
Monogram robot wins FDA OK; Vicarious hit by supplier woes
Monogram Technologies secured 510(k) clearance for its robotic knee replacement system, while Vicarious Surgical blamed supply chain issues for delaying its regulatory timeline.
By Susan Kelly • March 19, 2025 -
Retrieved from Insulet on March 18, 2025
Insulet Chief Technology Officer Mark Field leaves
Amit Guliani, group vice president of software engineering, was named acting chief technology officer, effective immediately.
By Elise Reuter • March 18, 2025 -
Courtesy of Nucor Steel Tuscaloosa.
Tariff uncertainty sparks manufacturing anxiety, especially among small firms
Shifting foreign suppliers could become more difficult as the Trump administration continues to enact new widespread tariff policies.
By Kate Magill • March 18, 2025 -
Top device firms report safety data late: BMJ
BD, Medtronic and Abbott were among the top 10 device companies with the highest number of late reports to the FDA, the study found.
By Elise Reuter • March 18, 2025 -
Retrieved from Spectral AI on March 18, 2025
Spectral AI algorithms beat physicians in burn tissue assessments
The company plans to file the results with the FDA by mid-2025 and launch the product in 2026.
By Nick Paul Taylor • March 18, 2025 -
4 takeaways from AAOS 2025
Stryker unveiled its updated Mako surgical robot and orthopedic companies expect procedure volumes to remain steady despite recession fears.
By Elise Reuter • March 17, 2025 -
FDA adds hemodialysis devices to shortage list amid B. Braun disruption
The disruption is expected to impact patient care, may require adjustments to the management of hemodialysis patients and could continue through the early fall of 2025.
By Nick Paul Taylor • March 17, 2025 -
Dr. Oz stresses need for faster Medicare coverage of new devices during confirmation hearing
Mehmet Oz, President Trump’s pick to lead the CMS, said Medicare beneficiaries should have quicker access to new medical devices once they’re FDA-approved.
By Ricky Zipp • March 14, 2025 -
Vicarious Surgical appoints Sarah Romano as CFO
Romano will arrive at the robotics company just as Chief Operating Officer John Mazzola is set to retire on April 1.
By Nick Paul Taylor • March 14, 2025 -
EPA to reconsider emissions standards for medical device sterilizers
Last year, the EPA issued a final rule that would limit emissions of ethylene oxide, a cancer-causing gas used to sterilize medical devices.
By Elise Reuter • March 13, 2025 -
Retrieved from Screenshot: Johnson & Johnson on March 13, 2025
J&J’s Monarch robot wins FDA nod for AI software update
Using Nvidia and GE Healthcare technology, the robotic surgery system is intended to help doctors detect lung cancer earlier.
By Susan Kelly • March 13, 2025 -
Vivani to spin off neurostimulation business
The independent company will trade as Cortigent and advance brain implants to help people recover body functions such as vision and movement.
By Nick Paul Taylor • March 13, 2025 -
FDA accuses Mid-Link of copying or falsifying medical device test data
The agency will reject all data from the Chinese service provider’s studies after Mid-Link failed to address concerns outlined in a warning letter last year, FDA officials said.
By Nick Paul Taylor • March 12, 2025 -
Capstan brings surgical robot to valve replacement
Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first patient implants.
By Susan Kelly • March 11, 2025 -
ECRI warns insufficient AI governance threatens patient safety
ECRI included other medtech-related threats on its list of patient safety concerns, noting that cybersecurity breaches can delay care and diagnostic errors can lead to improper treatment.
By Nick Paul Taylor • March 11, 2025 -
Orthofix’s fired execs’ lewd, ‘graphic’ texts surface in legal battle
Orthofix didn’t originally specify the reasons behind the 2023 firing of its CEO, CFO and CLO. Now, a court case is illuminating the story behind the terminations.
By Maura Webber Sadovi • March 10, 2025 -
New FDA pulse oximetry guidelines could stall under Trump
The draft guidance addresses criticisms that pulse oximeters are less accurate for people with dark skin tones. Experts raised concerns that it might not be finalized.
By Elise Reuter • March 10, 2025 -
Dexcom receives warning letter based on FDA inspections of 2 plants
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek clearance for new products.
By Nick Paul Taylor • March 10, 2025 -
FTC challenges $627M private equity takeover of Surmodics
The regulator said the buyout “would lead to a highly concentrated market for outsourced hydrophilic coatings and eliminate significant head-to-head competition.”
By Nick Paul Taylor • March 7, 2025